drugset / Trial / NCT04181749
Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography
Phase 2
Unknown
200 enrolled
University of Leicester
British Heart Foundation · collabNational Institute for Health Research, United Kingdom · collabUniversity of Oxford · collab
RandomizedParallel-groupOpen-labelDiagnostic
Summary
The P-VECT Study proposes to test the use of CCTA-derived FAI measurements in a group of patients with coronary artery inflammation, who will receive routinely-used statin and aspirin treatment. The P-VECT Study is a pilot study that will provide the rationale and data for power calculations to enable design of pivotal trials of the clinical effectiveness of FAI.
Timeline
- Start
- 2020-11-18
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 75 mg | — |
| Comparator | Atorvastatin | Small molecule | 40 mg | — |
Indications
No indication recorded.